Oxytocin Infusion and Abdominal Myomectomy

Phase 3

Completed

• Conditions: Oxytocin and Abdominal Myomectomy

• Registration Number: NCT03702946
• Lead Sponsor: Armed Forces Hospital, Pakistan

Brief Summary

Objective:To compare oxytocin infusion with control, in patients undergoing abdominal myomectomy in terms of mean blood loss.

Design: Single blinded randomized control trial Setting: Obstetrics and Gynecology Department, Military Hospital, Rawalpindi Population: 60 women of ASA class I-II, with intramural fibroids, candidate for elective abdominal myomectomy.

Methods: Women were divided into two groups randomly. In the study group 30 Units of oxytocin in 1000 ml normal saline were given during surgery, at the rate of 15units/hour. In control group, pure normal saline was given.

Main outcome measure: Intra-operative blood loss

Detailed Description

Not available

Study Timeline

• Study Start: 2017-07-15
• Primary Completion: 2018-01-15
• Study Completion: 2018-01-15
• Status Verified: 2018-10
• Study First Submitted: 2018-10-06
• Study First Submitted QC: 2018-10-09
• Last Update Submitted: 2018-10-09
• Study First Posted: 2018-10-11
• Last Update Posted: 2018-10-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

1. women of ASA class I-II with intramural fibroids,
2. women planned to undergo elective abdominal myomectomy

Exclusion Criteria

1. Women with hemoglobin (Hb) < 10g/dl
2. Women with any respiratory or cardiovascular disease.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Intra-operative blood loss	during the surgical procedure	average intra operative blood loss was measured

Trial Locations

Locations (2)

Department of Pediatrics; 🇵🇰 Rawalpindi, Punjab, Pakistan

Military Hospital; 🇵🇰 Rawalpindi, Punjab, Pakistan